Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Rexahn Pharmaceuticals, Inc. (RNN)

Rexahn Pharmaceuticals, Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:RNN
DateTimeSourceHeadlineSymbolCompany
06/11/201922:03Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
06/11/201915:30Edgar (US Regulatory)Unknown (sec Staff)AMEX:RNNRexahn Pharmaceuticals, Inc.
06/11/201915:30Edgar (US Regulatory)Unknown (sec Staff)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/08/201921:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/08/201911:46Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/08/201912:02Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/08/201911:44Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
10/06/201914:32Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:56Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:41Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201921:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RNNRexahn Pharmaceuticals, Inc.
07/06/201919:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/05/201917:58Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
28/05/201921:10GlobeNewswire Inc.Rexahn Announces Move to NasdaqAMEX:RNNRexahn Pharmaceuticals, Inc.
13/05/201913:00GlobeNewswire Inc.Rexahn Pharmaceuticals Reports First Quarter 2019 Financial ResultsAMEX:RNNRexahn Pharmaceuticals, Inc.
10/05/201921:22Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RNNRexahn Pharmaceuticals, Inc.
29/04/201921:45Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:RNNRexahn Pharmaceuticals, Inc.
16/04/201913:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
16/04/201913:00GlobeNewswire Inc.Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater ChinaAMEX:RNNRexahn Pharmaceuticals, Inc.
12/04/201913:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
12/04/201913:00GlobeNewswire Inc.Rexahn Effects 1-for-12 Reverse Stock SplitAMEX:RNNRexahn Pharmaceuticals, Inc.
10/04/201921:07GlobeNewswire Inc.Rexahn Announces Reverse Stock SplitAMEX:RNNRexahn Pharmaceuticals, Inc.
27/03/201912:00GlobeNewswire Inc.Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual MeetingAMEX:RNNRexahn Pharmaceuticals, Inc.
26/03/201920:15Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
11/03/201910:55Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RNNRexahn Pharmaceuticals, Inc.
 Showing the most relevant articles for your search:AMEX:RNN